Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
Clinical trial NCT02652455 · COMPLETED
Trial details
- NCT number
- NCT02652455
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2020-08-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.